Variant:
rs1801028 at chr11:113283484 in DRD2 (VIP)

Alleles (on + chromosomal strand)
G > C
Amino Acid Translation
Ser311Cys
Alternate Names:
DRD2:1097C>G, DRD2:Ser311Cys, c.845C>G, c.932C>G, g.16845900G>C, g.67518C>G, p.Ser282Cys, p.Ser311Cys

Variant Annotations

PharmGKB variant annotations provide information about variant-drug pairs based on individual PubMed publications. Each annotation represents information from a single paper and the goal is to report the information that the author states, not an interpretation of the paper. The PMID for supporting PubMed publications is found in the "Evidence" field.

Information presented, including study size, allele frequencies and statistics is taken directly from the publication. However, if the author does not correct p-values in cases of multiple hypotheses, curators may apply a Bonferroni correction. Curators attempt to report study size based on the actual number of participants used for the calculation of the association statistics, so the number may vary slightly from what is reported in the abstract of the paper. OMB Race Category information is derived from the paper and mapped to standardized categories. Category definitions may be found by clicking on the "OMB Race Category" link.

There are 1 annotations for this variant. Register or sign in to see them.

VIP Variant in DRD2

It is not clear whether the Ser311Cys polymorphism is associated with schizophrenia. There have been reports both supporting and refuting such results. This variant is a C>G SNP in exon 7 that alters the codon 311 from the more common Ser to the less common Cys. The Cys311 variant has decreased affinity for dopamine [Article:8824240]. The minor allele frequency (G allele) is 0.02 based on the 102 individuals of self-described heritage (African/African American, n=24, Caucasian, n=31, Hispanic, n=23, and Pacific Rim, n=24) see dbSNP. From the same data set, the frequency of the G allele is higher in a self-described Pacific Rim population (0.043) than that in a Caucasian population (0.016).
There is published evidence both supporting [Articles:7907680, 7909081, 8723039, 11011590, 12707934, 16402354] and refuting [Article:9650635] the association between Ser311Cys polymorphism of the DRD2 gene and schizophrenia. A possible link between the Cys allele of 311 Ser>Cys in DRD2 and schizophrenia was first reported in the mid 1990s [Articles:7907680, 7909081, 8723039], although Goldman et al. found no correlation between carriers of Cys 311 and schizophrenia in a Native American population [Article:9650635]. Jonsson et al. examined the possible association of Ser311Cys and schizophrenia in control and schizophrenic populations, both of Swedish origin [Article:12707934]. The schizophrenic patient population (n = 173) showed a higher allele frequency of Cys 311 than the control population (n = 236) [Article:12707934]. Interestingly, this association was detected only in male patients [Article:12707934]. In a more recent study by Glatt and Jonsson [Article:16402354], an analysis was conducted of several different studies which contained a total of 3,707 schizophrenia patients and 5,363 control subjects. The authors found that the Cys 311 allele had a significant effect [Article:16402354]. In the same study, the authors reported that Cys/Ser heterzygotes were at increased risk for schizophrenia as compared to the Ser/Ser homozygotes, but there was no increased risk detected for Cys/Cys homozygotes [Article:16402354].

Note: The DRD2 gene is found on the minus chromosomal strand. Please note that for standardization, the PharmGKB presents all allele base pairs on the positive chromosomal strand, therefore the alleles within our variant annotations will differ (in a complementary manner) from those in this VIP summary that are given on the minus strand as reported in the literature.

Key Publications:
Diseases Schizophrenia 1 2 3

Appendix

DRD2: Ser311Cys

Genomic Variant & GenBank ID: 16845900 G>C on NT_033899.7
mRNA Variant & GenBank ID: 1097 C>G on NM_000795.2
1010 C>G on NM_016574.2
Protein Variant & GenBank ID: 311 Ser> Cys on NP_000786 (long isoform)
282 Ser>Cys on NP_057658 (short isoform)
gp Positionchr:112788694(hg18)

Connected Drugs

Evidence Drug
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
aripiprazole

Connected Diseases

Evidence Disease
Schizophrenia

Publications related to rs1801028 at chr11:113283484: 5

No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients. Journal of psychiatric research. 2009. Shen Yu-Chih, et al. [Article:18926547@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2006. Glatt Stephen J, et al. [Article:16402354@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2003. Jönsson Erik G, et al. [Article:12707934@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse. Alcohol (Fayetteville, N.Y.). 1998. Goldman D, et al. [Article:9650635@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Functional analysis of the human D2 dopamine receptor missense variants. The Journal of biological chemistry. 1996. Cravchik A, et al. [Article:8824240@PubMed]

Cross-References

UCSC Golden Path:
chr11:113283484
dbSNP:
rs1801028
ALFRED:
SI000138M

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.